Humoral and cellular immune responses to CoronaVac up to one year after vaccination (2022)
- Authors:
- USP affiliated authors: COSTA, PRISCILLA RAMOS - FM ; KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.3389/fimmu.2022.1032411
- Subjects: COVID-19; VACINAS VIRAIS; SISTEMA IMUNE; CITOCINAS; ANTÍGENOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 13, article ID 1032411, 15p, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
COSTA, Priscilla Ramos et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50534. Acesso em: 09 nov. 2024. -
APA
Costa, P. R., Correia, C. A., Marmorato, M. P., Dias, J. Z. de C., Thomazella, M. V., Silva, A. C. da, et al. (2022). Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.1032411 -
NLM
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534 -
Vancouver
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534 - Avaliação do perfil de ativação de células T nas fases recente e estabelecida de infecções por subtipos C e não C do vírus HIV-1
- Lower numbers of natural killer T cells in HIV-1 and mycobacterium leprae co-infected patients
- No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
- Streamlining HIV Testing for HIV Preexposure Prophylaxis
- HLA-C downregulation by HIV-1 adapts to host HLA genotype
- Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
- Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
- Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial
- Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
Informações sobre o DOI: 10.3389/fimmu.2022.1032411 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
